Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice-Reference-Cited by-同舟云学术

Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice

Published:2022-03-02 Issue:1 Volume:19 Page:36-43
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

O'Bryant Sid E.¹,Petersen Melissa¹²,Hall James¹,Johnson Leigh A.¹³,

Affiliation:

1. Institute for Translational Research University of North Texas Health Science Center Fort Worth Texas USA

2. Department of Family Medicine University of North Texas Health Science Center Fort Worth Texas USA

3. Department of Pharmacology and Neuroscience University of North Texas Health Science Center Fort Worth Texas USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12647

Reference52 articles.

1. Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

2. Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older Adults

3. High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis

4. High performance plasma amyloid-β biomarkers for Alzheimer’s disease

5. Plasma p‐tau 181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer’s disease biomarkers and their current use in clinical research and practice;Molecular Psychiatry;2024-09-04

2. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies;Signal Transduction and Targeted Therapy;2024-08-23

3. Biomarkers of sleep-wake disturbance as predictors of cognitive decline and accelerated disease progression;Expert Review of Molecular Diagnostics;2024-08-02

4. A Comparative Analysis of Two Automated Quantification Methods for Regional Cerebral Amyloid Retention: PET-Only and PET-and-MRI-Based Methods;International Journal of Molecular Sciences;2024-07-12

5. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup;Alzheimer's & Dementia;2024-06-27